Transcode Therapeutics, Inc (RNAZ) insider trading
Every open-market stock purchase and sale by Transcode Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Robert Michael Dudley (CEO), $50K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.72 on Oct 22, 2026.
Recent RNAZ insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 9, 2026 | Thomas A Fitzgerald (CFO) | Bought (not open market) | — |
| Aug 3, 2026 | Defj LLC (10% owner) | Bought (not open market) | — |
| Aug 3, 2026 | Defj LLC (10% owner) | Bought (not open market) | — |
| Aug 3, 2026 | Defj LLC (10% owner) | Bought (not open market) | — |
| Aug 3, 2026 | Defj LLC (10% owner) | Bought (not open market) | — |
Who's trading RNAZ
- Thomas A Fitzgerald, CFO: other filings, last Sep 9, 2026
- Defj LLC, 10% owner: other filings, last Aug 3, 2026
Get free alerts when an insider at Transcode Therapeutics, Inc files a new trade →